Notable Labs Corp (NTBL) Cash Funds per Share

Notable Labs Corp - graphic logo of issuer NTBL

Notable Labs, Ltd. (NTBL) is facing logistics disruptions and patent complexities driven by global conflicts. Cash per share confirms this, with the parameter mark equal to 0.00. The implementation of a unique therapy selection system in clinics provides a stable income stream. However, high development costs and limited liquidity reserves necessitate strict expense control for the startup's survival.

NTBL Notable Labs Ltd: Cash per Single Share in the range 02/21/2024 - 11/02/2024

Comprehensive metric breakdowns and analytics for notablelabs.com (NTBL)

- stock quotes and analyst forecast:
- cash availability and cash flow indicators:
Summary company analysis:Notable Labs Corp
Brand item of Notable Labs, Ltd.

Cash per share determines the issuer's actual liquidity, excluding market volatility. By analyzing the trend of cash reserves per share, an investor can see the business's actual cash cushion. This metric is calculated by dividing the total volume of available cash by the number of shares outstanding. For Notable Labs, Ltd. (NTBL), such a metric is critical due to the high capital burn associated with the development of its IT platform. A decline in this indicator confirms the company's dependence on external financing amid a revenue deficit.

Analysis of competing companies

Cash Funds per Single Share ONC (BeiGene Corp)|Cash per Single Share HALO (Halozyme Therapeutics, Inc.)|Cash per Share Revolution Medicines, Inc. (RVMD)|Cash per Share AAPG (ascentage.com)|CG Oncology Inc (CGON) - Cash on Hand per Share|URGN - Cash Funds per Share|Bicara Bio - Cash Calculated per Single Share|PSNL: Cash per Share|Cash Funds per Single Share ERAS|Cash per Single Share DCTH|Cash on Hand per Share Y-mAbs Therapeutics Inc YMAB|Cash per Share AURA|CADL (Candel Therapeutics, Inc.) - Amount of Cash per Share|Cash Funds per Share Accuray Inc ARAY|Cash Funds Calculated per Share SELLAS Life Sciences Group Inc. (SLS)|actuatetherapeutics.com - Cash per Share|Cash on Hand per Share Citius Oncology|HURA: Cash per Share|Cash Money per Share TARA (Protara)|FATE (fatetherapeutics.com) - Cash per Share|Cash on Hand per Share Aadi Bioscience WHWK|Cash per Share TCRX|CSBR - Cash on Hand per Share|XBiotech - Cash per Single Share|CEL-SCI Corporation (CVM) - Cash on Hand per Share|OSTX - Cash Funds per Share|Cash on Hand per Share Radiopharm Theranostics Ltd|ARTV (artivabio.com) - Cash per Single Share|ANL (Adlai Nortye Ltd) - Cash Funds per Share|Cash per Single Share VERU|Tempest Therapeutics (TPST) - Cash Funds Calculated per Share|Cash per Share XLO|Cash per Single Share Renovaro RENB|Cash per Share MURA (Mural Oncology PLC)|KAPA - Cash per Single Share|OnKure Therapeutics - Cash per Share|w2.cytomed.sg - Cash Calculated per Single Share|Curis Corp (CRIS) - Cash Funds per Share|Cash on Hand per Share Apollomics Corp (APLM)|Cash Funds per Share Tharimmune|Cash per Share advanbiomed.com|Cash Funds per Share Genprex, Inc (GNPX)|Cash Funds Calculated per Share Calidi Biotherapeutics, Inc.|Cash per Share SBFM (Sunshine Biopharma Inc.)|XBIO - Cash per Single Share|SLRX: Cash per Single Share|Amount of Cash per Share PPBT (Purple Biotech Ltd.)|AONC: Cash per Share|Cash on Hand per Share BeOne Medicines (BGNE)|Cash Funds per Share Checkpoint Therapeutics, Inc.|Cash per Single Share Elevation Oncology (ELEV)|Cash Funds per Share iCAD Corp (ICAD)|Cash per Single Share Ikena IKNA|Cash per Share VIRX (Viracta Therapeutics)|Cash Funds Calculated per Share MorphoSys AG (MOR)|NAYA Biosciences Corp - Cash per Share|Cash on Hand per Share ascentage.com